Alkem Laboratories Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-09-04 | −3111.94 | +8930.12 |
| 2026-09-03 | −2345.87 | +4977.46 |
| 2026-09-02 | +6688.37 | +2812.98 |
| 2026-09-01 | −7985.88 | +4588.88 |
| 2026-08-31 | −7985.88 | +4588.88 |
Today's Institutional Flow
Foreign Institutional Investors (FII) posted a net cash outflow of ₹‑3,111.94 Cr today, while Domestic Institutional Investors (DII) recorded a net cash inflow of ₹ 8,930.12 Cr, indicating a strong reversal in sentiment on the day. The FII cash outflow contrasts sharply with the DII’s substantial buying, suggesting that domestic funds are stepping in to support market liquidity. Overall, the net institutional cash flow is positive by roughly ₹ 5,818 Cr, driven almost entirely by the DII side.
Trend vs 5-Day Average
Today's FII cash outflow of ₹‑3,111.94 Cr is less severe than the five‑day average outflow of ₹‑3,333.81 Cr, implying a slight easing of pressure from foreign investors. In contrast, the DII inflow of ₹ 8,930.12 Cr exceeds the five‑day average buying of ₹ 4,430.43 Cr, underscoring a continuation of robust domestic buying momentum.
F&O Positioning Data
FII positions in futures and options posted a net long exposure of ₹ 374,795 Cr, reflecting a sizeable speculative tilt despite the cash outflow. The index futures long-to-short ratio stands at 1.2, indicating that long contracts modestly outweigh shorts among foreign participants.
Healthcare Sector Flow
The healthcare segment, of which Alkem Laboratories is a key constituent, has seen a cumulative ₹ 2,200 Cr net inflow from FIIs and DIIs over the past week, pointing to a consistently bullish bias in the sector.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04